Introduction
Numerous methods of managing parotid fistulae have been described in recent years. These include various types of surgery (1, 3, 4) , tympanic neurectomy (5), a conservative approach by applying dressings (16) or administering no food orally until healing occurs (11) , the use of botulinum toxin (7, 8, 15) , glycopyrrolate (2) , octreotide (13) or injection of a solution of lipiodol with cyanoacrylate (9) . Up till now, none of these treatments proved to have a clear advantage over the others.
Here we present, to our knowledge for the first time, the management of two cases of postparotidectomy fistulae using fibrin glue (Tissucol ® Duo 500, Baxter AG, Vienna, Austria).
Case reports
Patient A In 1994 a chronically inflamed epidermal cyst behind the left ear lobe was removed in a then 52-year-old man. The lesion already persisted for many years, albeit smaller in size, and had been incised before in another hospital. Due to the chronic character, the decision was made to extirpate the lesion. Intraoperative findings suggested that the cyst spread via the parotic gland. Although there were no immediate postoperative problems, after some months the inflammation reappeared. An additional fistulogram showed a blind ending 2-cm long fistula. The ongoing inflammation eventually led to a superficial parotidectomy in 1996.
Unfortunately the fistula reappeared again and another attempt was made to remove it radically in 1998. The fistula was excised and the wound was primary closed. Due to a series of major vascular operations the fistula related problems moved to the background for the next few years. However, in 2003 the patient addressed our outpatient clinic again. He mentioned loss of saliva through three holes behind the left ear lobe, particularly when eating candy. Again a sialogram was made which depicted a 2-cm long fistula ending blindly. No connection with deeper structures was shown. Since surgery obviously failed to adequately heal the fistula we performed a literature search. Positive reports on the use of fibrin glue in anal fistula drew our attention and we decided to use Tissucol on our patient. The area of the fistula opening was disinfected using alcohol 70% and sterile drapes were placed. The glue was prepared according to the manufacturers' instructions. A flexible catheter was introduced into the fistula tract as deeply as possible without resistance and then slowly withdrawn while injecting one to two milliliters of glue. Already one week after injection the leakage of saliva had diminished considerably while the inflammation had decreased. After a final control eight weeks later the patient was discharged and over the last two years no further problems have arisen.
Patient B
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Discussion
Postparotidectomy fistulae represent a major complication in parotic surgery with an prevalence of up to 14% (16) . Since many years physicians have tried to avoid and heal postparotidectomy fistulae through various ways. Some authors recommend applying dressings (16) with the disadvantage that patients have to maintain these dressings for several days. Others prefer the rather Spartan treatment of administering no food orally until healing occurs (11) . Alternatively, there is the possibility of surgical intervention (1,3,4) such as parotidectomy or tympanic neurectomy (5). Obviously, this carries the risk of infection and damage to the facial nerve.
In more recent years attention has focussed on treatment with chemicals such as Botulinum toxin (7, 8, 15) glycopyrrolate (2) and octreotide (13) . The former two agents display an anticholinergic effect, with serious side effects that are well known, including constipation, insomnia, nausea and vomiting. Although glycopyrrolate seems to have fewer side effects than Botulinum toxin because of its inability to cross the blood-brain barrier, it is better to avoid these chemicals if possible. Octreotide was first administered by Spinell e.a. in 1995 (13) . Despite the fact that a positive effect on the fistulae was detected it should be noted that the drug has to be administered systemically. Because the exact mechanism of its action is not completely known care should be taken to use octreotide for postparotidectomy fistulae.
A rather different strategy was described by Marcus e.a. (9) . They injected a solution of lipiodol and cyanoacrylate tissue adhesive inside the fistulae of several patients. This agent polymerizes on contact with saliva, causing an exothermic reaction and subsequent closure of the fistula. However, patients described discomfort following injection of the chemical, making this procedure less feasible, particularly since repetitive injections were necessary. Nevertheless, the idea of sealing fistulae together is very interesting but instead of using cyanoacrylate it may be advantageous to use fibrin tissue adhesives, because of the different mechanism of action. Cyanoacrylates are synthetic and have been shown to be histotoxic when applied below the dermis and are used most successfully at the level of the epidermis for superficial skin closure (10, 14) . Fibrin glues on the other hand are naturally occurring substrates that are part of normal endogenous clotting mechanisms and are typically applied below the dermis. They are packaged as two separate components that, when mixed on human tissue, simulate the interaction of the endogenous compounds and form a fibrin clot. For these reasons, we decided to focus on the feasibility of fibrin glue with respect to the management of postparotidectomy fistulae. There are several types of fistulae that have been treated with fibrin glue over the last years, but we did not find any article describing the management of postparotidectomy fistulae using this strategy. Examples of healing fistulae with fibrin tissue sealant include esophagothoracocutaneous fistulae (12) and urinary fistulae (6) . Overall the results are promising and complication rates are low, but it must be noticed that no major randomised clinical trials have been undertaken. Nevertheless, treatment with fibrin glue is safe and has no side effects, contrary to the other therapies applied thusfar. In this paper we show that injection of postparotidectomy fistulae with fibrin glue resulted in quick healing. Moreover, in both patients no recurrence of the disease was detected. Therefore, we believe that managing these fistulae with fibrin tissue adhesive requires further study and may well prove to be the treatment of choice.
